Erector Spinae Plane Block Versus Quadratus Lumborum Block For Postoperative Analgesia After Abdominal Hysterectomy

September 15, 2022 updated by: Khaled Abdou, Ain Shams University

Erector Spinae Plane Block Versus Quadratus Lumborum Block For Postoperative Analgesia After Abdominal Hysterectomy; A Randomized Comparative Study

The aim of this study is to compare the analgesic efficacy of erector spinae plane block and quadratus lumborum block after abdominal hysterectomy surgery and postoperative opioid consumption.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Ain Shams Univerisity
        • Contact:
        • Principal Investigator:
          • Khaled Abdou, MD
        • Sub-Investigator:
          • Marrwa Salem, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

38 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients with American Society of Anesthesiologists (ASA) physical status 1-3.
  • scheduled for abdominal hysterectomy surgery.

Exclusion Criteria:

  • History of allergy to the medications used in the study.
  • Contraindication to regional anesthesia as coagulopathy, local infection.
  • Severe hepatic impairment (child C).
  • Sever Renal dysfunction (creatinine clearance < 30).
  • Psychiatric or mental disorder affecting patient ability to interpret VAS score.
  • Body mass index (BMI) ≥ 40 or ≤ 18 kg/m2.
  • ASA IV.
  • Patient refusal.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ESPB
Erector Spinae Plane Block group
ultrasound guided nerve block
Active Comparator: QLB
Quadratus Lumborum Block group
ultrasound guided nerve block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative pain
Time Frame: 24 hours
Post-operative pain severity assessed by visual analog scale (VAS) (range from 0-10., 0 no pain, 10 worst pain ).
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative post-operative opioid consumption
Time Frame: 24 hours
opioid consumption
24 hours
The onset of 1st analgesic request
Time Frame: 24 hours
time needed for 1st request of rescue analgesia
24 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of complications
Time Frame: 24 hours
postoperative nausea and vomiting(PONV), hematoma, local anaesthetic toxicity (LAT)
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2022

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

January 1, 2023

Study Registration Dates

First Submitted

September 13, 2022

First Submitted That Met QC Criteria

September 13, 2022

First Posted (Actual)

September 15, 2022

Study Record Updates

Last Update Posted (Actual)

September 19, 2022

Last Update Submitted That Met QC Criteria

September 15, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • ASUKH1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on peripheral nerve block

3
Subscribe